These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 29953893)
21. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery. Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265 [TBL] [Abstract][Full Text] [Related]
22. Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chondroitin sulfate nanoparticles. Jardim KV; Joanitti GA; Azevedo RB; Parize AL Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():294-304. PubMed ID: 26249593 [TBL] [Abstract][Full Text] [Related]
23. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
24. A novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles/polymersomes for curcumin delivery to cancer cells. Erfani-Moghadam V; Nomani A; Zamani M; Yazdani Y; Najafi F; Sadeghizadeh M Int J Nanomedicine; 2014; 9():5541-54. PubMed ID: 25489242 [TBL] [Abstract][Full Text] [Related]
25. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung. Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944 [TBL] [Abstract][Full Text] [Related]
26. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
27. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer. Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296 [TBL] [Abstract][Full Text] [Related]
28. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery. Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499 [TBL] [Abstract][Full Text] [Related]
29. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment. Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578 [TBL] [Abstract][Full Text] [Related]
30. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Jiang HL; Xu CX; Kim YK; Arote R; Jere D; Lim HT; Cho MH; Cho CS Biomaterials; 2009 Oct; 30(29):5844-52. PubMed ID: 19640582 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and characterization of Fe Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247 [TBL] [Abstract][Full Text] [Related]
32. Water-soluble substituted chitosan derivatives as technology platform for inhalation delivery of siRNA. Capel V; Vllasaliu D; Watts P; Clarke PA; Luxton D; Grabowska AM; Mantovani G; Stolnik S Drug Deliv; 2018 Nov; 25(1):644-653. PubMed ID: 29493294 [TBL] [Abstract][Full Text] [Related]
33. [Chitosan-siRNA complex nanoparticles for gene silencing]. Liu X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033 [TBL] [Abstract][Full Text] [Related]
34. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. Jose A; Labala S; Venuganti VV J Drug Target; 2017 Apr; 25(4):330-341. PubMed ID: 27819148 [TBL] [Abstract][Full Text] [Related]
35. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing. Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703 [TBL] [Abstract][Full Text] [Related]
36. Nebulized anionic guanidinylated O-carboxymethyl chitosan/N-2-hydroxypropyltimehyl ammonium chloride chitosan nanoparticles for siRNA pulmonary delivery: preparation, characterization and in vitro evaluation. Ni S; Xie Y; Tang Y; Liu Y; Chen J; Zhu S J Drug Target; 2017 Jun; 25(5):451-462. PubMed ID: 28110554 [TBL] [Abstract][Full Text] [Related]
37. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347 [TBL] [Abstract][Full Text] [Related]
38. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo. Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190 [TBL] [Abstract][Full Text] [Related]
39. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047 [TBL] [Abstract][Full Text] [Related]
40. Development of Enteromorpha prolifera polysaccharide-based nanoparticles for delivery of curcumin to cancer cells. Li J; Jiang F; Chi Z; Han D; Yu L; Liu C Int J Biol Macromol; 2018 Jun; 112():413-421. PubMed ID: 29410267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]